Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor

References

• Bao W, Zhou J, Luo J, et al. (2006). PLGA microspheres with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique. J Microencapsul 23:471–9.
   PubMed Web of Science ®Google Scholar
• Brown KT, Do RK, Gonen M, et al. (2016). Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone. JCO 34:2046–53.
   PubMed Web of Science ®Google Scholar
• Buijs M, Geschwind JF, Syed LH, et al. (2012). Spontaneous tumor regression in a syngeneic rat model of liver cancer: implications for survival studies. J Vasc Interv Radiol 23:1685–91.
   PubMed Web of Science ®Google Scholar
• Cao J, Wang R, Gao N, et al. (2015). A7RC peptide modified paclitaxel liposomes dually target breast cancer. Biomater Sci 3:1545–54.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yoon HY, Koo H, et al. (2011). Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel. Biomaterials 32:7181–90.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yoon IS, Yoon HY, et al. (2012). Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Biomaterials 33:1190–200.
   PubMed Web of Science ®Google Scholar
• Choi JW, Cho HJ, Park JH, et al. (2014). Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads. PLoS One 9:e115898
   PubMed Web of Science ®Google Scholar
• Choi JW, Kim JH, Kim HC, et al. (2016). Comparison of tumor vascularity and hemodynamics in three rat hepatoma models. Abdom Radiol (NY) 41:257–64.
   PubMed Web of Science ®Google Scholar
• Choi JW, Park JH, Baek SY, et al. (2015). Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor. Colloids Surf B Biointerfaces 132:305–12.
   PubMed Web of Science ®Google Scholar
• Choi JW, Park JH, Cho HR, et al. (2017). Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor. Sci Rep 7:554
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. (2012). PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505–22.
   PubMed Web of Science ®Google Scholar
• Du D, Chang N, Sun S, et al. (2014). The role of glucose transporters in the distribution of p-aminophenyl-α-d-mannopyranoside modified liposomes within mice brain. J Control Release 182:99–110.
   PubMed Web of Science ®Google Scholar
• Dutta R, Mahato RI. (2017). Recent advances in hepatocellular carcinoma therapy. Pharmacol Ther 173:106–17.
   PubMed Web of Science ®Google Scholar
• Facciorusso A. (2018). Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: current state of the art. World J Gastroenterol 24:161–9.
   PubMed Web of Science ®Google Scholar
• Gao S, Yang Z, Zheng Z, et al. (2013). Doxorubicin-eluting bead versus conventional TACE for unresectable hepatocellular carcinoma: a meta-analysis. Hepatogastroenterology 60:813–20.
   PubMedGoogle Scholar
• Genco C, Cabibbo G, Maida M, et al. (2013). Treatment of hepatocellular carcinoma: present and future. Expert Rev Anticancer Ther 13:469–79.
   PubMed Web of Science ®Google Scholar
• Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, et al. (2016). Hepatocellular carcinoma: from diagnosis to treatment. Surg Oncol 25:74–85.
   PubMed Web of Science ®Google Scholar
• Hu R, Zheng H, Cao J, et al. (2017a). Self-assembled hyaluronic acid nanoparticles for pH-sensitive release of doxorubicin: synthesis and in vitro characterization. J Biomed Nanotechnol 13:1058–68.
   PubMed Web of Science ®Google Scholar
• Hu R, Zheng H, Cao J, et al. (2017b). Synthesis and in vitro characterization of carboxymethyl chitosan-CBA-doxorubicin conjugate nanoparticles as pH-sensitive drug delivery systems. J Biomed Nanotechnol 13:1097–105.
   PubMed Web of Science ®Google Scholar
• Idée JM, Guiu B. (2013). Use of lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review. Crit Rev Oncol Hematol 88:530–49.
   PubMed Web of Science ®Google Scholar
• Jeong JY, Hong EH, Lee SY, et al. (2017). Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration. Acta Biomater 53:414–26.
   PubMed Web of Science ®Google Scholar
• Jia F, Liu X, Li L, et al. (2013). Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents. J Control Release 172:1020–34.
   PubMed Web of Science ®Google Scholar
• Jin YJ, Termsarasab U, Ko SH, et al. (2012). Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma. Pharm Res 29:3443–54.
   PubMed Web of Science ®Google Scholar
• Kim HC. (2017). Radioembolization for the treatment of hepatocellular carcinoma. Clin Mol Hepatol 23:109–14.
   PubMed Web of Science ®Google Scholar
• Lanza E, Donadon M, Poretti D, et al. (2016). Transarterial therapies for hepatocellular carcinoma. Liver Cancer 6:27–33.
   PubMed Web of Science ®Google Scholar
• Lau WM, Teng E, Chong HS, et al. (2014). CD44v8-10 is a cancer-specific marker for gastric cancer stem cells. Cancer Res 74:2630–41.
   PubMed Web of Science ®Google Scholar
• Lee EW, Khan S. (2017). Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma. Clin Mol Hepatol 23:265–72.
   PubMed Web of Science ®Google Scholar
• Lee JY, Termsarasab U, Park JH, et al. (2016). Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery. J Control Release 236:38–46.
   PubMed Web of Science ®Google Scholar
• Lee SY, Park JH, Ko SH, et al. (2017). Mussel-inspired hyaluronic acid derivative nanostructures for improved tumor targeting and penetration. ACS Appl Mater Interfaces 9:22308–20.
   PubMed Web of Science ®Google Scholar
• Lewis AL, Holden RR. (2011). DC Bead embolic drug-eluting bead: clinical application in the locoregional treatment of tumours. Expert Opin Drug Deliv 8:153–69.
   PubMed Web of Science ®Google Scholar
• Li MH, Yu H, Wang TF, et al. (2014). Tamoxifen embedded in lipid bilayer improves the oncotarget of liposomal daunorubicin in vivo. J Mater Chem B 2:1619–25.
   PubMed Web of Science ®Google Scholar
• Liang YJ, Yu H, Feng G, et al. (2017). High-performance poly(lactic-co-glycolic acid)-magnetic microspheres prepared by rotating membrane emulsification for transcatheter arterial embolization and magnetic ablation in VX2 liver tumors. ACS Appl Mater Interfaces 9:43478–89.
   PubMed Web of Science ®Google Scholar
• Misra S, Heldin P, Hascall VC, et al. (2011). Hyaluronan-CD44 interactions as potential targets for cancer therapy. Febs J 278:1429–43.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Kita R, Kimura T, et al. (2014). Arterial embolic therapies for hepatocellular carcinoma: a literature review. Anticancer Res 34:6877–86.
   PubMed Web of Science ®Google Scholar
• Park JH, Cho HJ, Termsarasab U, et al. (2014). Interconnected hyaluronic acid derivative-based nanoparticles for anticancer drug delivery. Colloids Surf B Biointerfaces 121:380–7.
   PubMed Web of Science ®Google Scholar
• Peng H, Liu X, Wang G, et al. (2015). Polymeric multifunctional nanomaterials for theranostics. J Mater Chem B 3:6856–70.
   PubMed Web of Science ®Google Scholar
• Pleguezuelo M, Marelli L, Misseri M, et al. (2008). TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther 8:1623–41.
   PubMed Web of Science ®Google Scholar
• Ramsey DE, Kernagis LY, Soulen MC, et al. (2002). Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 13:S211–21.
   PubMed Web of Science ®Google Scholar
• Wang L, Su W, Liu Z, et al. (2012). CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. Biomaterials 33:5107–14.
   PubMed Web of Science ®Google Scholar
• Wang Q, Cheng H, Peng H, et al. (2015). Non-genetic engineering of cells for drug delivery and cell-based therapy. Adv Drug Deliv Rev 91:125–40.
   PubMed Web of Science ®Google Scholar
• Zheng H, Yin L, Zhang X, et al. (2016a). Redox sensitive shell and core crosslinked hyaluronic acid nanocarriers for tumor-targeted drug delivery. J Biomed Nanotechnol 12:1641–53.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang H, Yin L, et al. (2016b). A pH-sensitive nanosystem based on carboxymethyl chitosan for tumor-targeted delivery of daunorubicin. J Biomed Nanotechnol 12:1688–98.
   PubMed Web of Science ®Google Scholar